Good health is vital to all of us, and finding sustainable solutions to cheap generic medicines for pressing health care challenges cannot wait. According to various studies, expenditure on medicines accounts for a major proportion of health care costs especially in developing countries where there are no proper medical plans or government support. It is also estimated that one-third of the developing world population are unable to receive or purchase essential medicines on a regular basis.
This is why we at Hermes are committed to applying science and our resources to improve global health and well-being through affordable API’s which in turn can lower the cost of medicines. For example we have filed a patent for a key intermediate of Donepezil which has reduced the cost of the API considerably. We are also looking to file multiple patents in the future for various therapeutic categories which will lead to affordable intermediates/API’s and will further lower the costs of medicines. We target different categories where we can innovate which is apparent by our diverse productportfolio such as medication for Alzheimer’s, Hepatitis C, Pain Management, Depressants, Parkinson’s disease, Fungals, Histaminics, Bacterial’s, Bladder Control etc. Which helps many different groups of people. In addition to quantity and pricing at Hermes we also believe in quality healthcare, hence at every step of the manufacturing process, we test and produce goods only to standards that are approved by major regulatory bodies.
At Hermes in addition to our customers, we also have our duties to our employees and shareholders. It is for these reasons we also innovate better processes which not only lead to better pricing of our products but also retains profitability for all stakeholders alike. We believe in utmost transparency and work with all our stakeholders to ensure that people everywhere have access to innovative treatments and quality health care.